|
|
|
|
EASL
43rd Annual Meeting of the European Association For The Study Of The Liver
Milan, Italy
April 23-27, 2008 |
Back  |
|
|
|
 |
 |
 |
|
New HCV Drugs Panel Discussion at EASL 2008
|
|
|
On the final morning at EASL several researchers were sat on a panel for discussion and provided presentations regarding new drugs in development for treating HCV. Here are selected slides from the morning session.
Jules Levin

Here is the life cycle of HCV and blowups of pictures of several targets for drug development and a list of several drugs the furthest along in development.
















|
|
|
 |
 |
|
|
|